Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 31068712.
- Also identified by DOI 10.1038/s41591-019-0437-z and PMC identifier 6557439.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 15-year-old patient with cystic fibrosis with a disseminated Mycobacterium abscessus infection was treated with a three-phage cocktail following bilateral lung transplantation. Effective lytic phage derivatives that efficiently kill the infectious M. abscessus strain were developed by genome engineering and forward genetics. Intravenous phage treatment was well tolerated and associated with objective clinical improvement, including sternal wound closure, improved liver function, and substantial resolution of infected skin nodules.
Medical subject headings
- Mycobacterium Infections, Nontuberculous
- Mycobacterium abscessus
- Phage Therapy